Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today
Key takeaways
- Treasury buybacks, a weaker dollar, and a Moderna breakthrough are propelling a broad market rally, especially in commodities and biotech.
- 10‑year Treasury yield fell 5 bps to 4.66%
- 30‑year Treasury yield fell 8 bps to 5.20%
- Gold rose to $4,500 an ounce
What happened
U.S. equities rebounded from a tech‑driven slump as the Treasury doubled its long‑dated debt buybacks, pulling 10‑ and 30‑year yields lower and weakening the dollar to its weakest level since late May. Gold surged to $4,500 an ounce, silver and platinum hit two‑month highs, and the S&P 500 added 0.6% to 7,735. Moderna stock jumped 132.7% to $146.52 after a positive mRNA cancer vaccine trial, while other sectors like consumer discretionary and materials also gained.
Why it matters
The Treasury’s buyback move signals continued fiscal support for the economy, easing borrowing costs and boosting risk‑seeking assets. The dollar’s decline lifts commodity prices and supports dollar‑sensitive stocks such as mining and crypto firms. Moderna’s breakthrough could reshape the oncology vaccine market and…
Short-term and longer-term
Short-term. Short‑term traders should watch the Treasury’s buyback schedule and the dollar index for further yield and commodity moves.
Longer-term. Over the next few months, the Treasury’s continued buybacks could keep borrowing costs low, supporting growth‑heavy sectors like biotech and technology.